Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2025

Feb 18, 2025

30016_dirs_2025-02-18_1ac03670-53db-4845-bb81-d4409626bbf3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2025-02-13

Reporting Person: Erickson Michael G (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-14 Common Stock M 69 Acquired 20905.3617 Direct
2025-02-14 Common Stock M 93 Acquired 20998.3617 Direct
2025-02-14 Common Stock M 94 Acquired 21092.3617 Direct
2025-02-14 Common Stock M 301 Acquired 21393.3617 Direct
2025-02-14 Common Stock F 177 $444.53 Disposed 21216.3617 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-13 Non-Qualified Stock Option (right-to-buy) $459.76 A 6320 Acquired 2035-02-12 Common Stock (6320) Direct
2025-02-13 Incentive Stock Option (right-to-buy) $459.76 A 217 Acquired 2035-02-12 Common Stock (217) Direct
2025-02-13 Restricted Stock Unit $ A 734 Acquired Common Stock (734) Direct
2025-02-13 Restricted Stock Unit $ A 734 Acquired Common Stock (734) Direct
2025-02-14 Restricted Stock Unit $ M 69 Disposed Common Stock (69) Direct
2025-02-14 Restricted Stock Unit $ M 93 Disposed Common Stock (93) Direct
2025-02-14 Restricted Stock Unit $ M 94 Disposed Common Stock (94) Direct
2025-02-14 Restricted Stock Unit $ M 301 Disposed Common Stock (301) Direct

Footnotes

F1: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.

F2: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.

F3: Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.

F4: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.

F5: Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2022.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2024.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2025.